![]() 1,088,721,977 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
NSCLC |
0.01 sec. |
How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content. |
|
? References in periodicals archive |
|---|
In this triple analysis report we have analyzed three major and intertwined areas of cancer R&D, Non Small Cell Lung Cancer Therapeutics, Protein Kinase Inhibitors and Anti- Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, will present additional data from the completed Phase I trial results for Talvesta[TM] (talotrexin) for Injection in non small cell lung cancer ( Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced that Phase I trials in solid tumors and non small cell lung cancer ( |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|